BioAngels Investors Network

Investors meet BioEntrepreneurs

BioAngels is an exclusive matchmaking concept for private investors such as business angels, wealthy individuals, family offices and conventional venture capital investors determined to invest in life sciences & health technology.

Matchmaking

We introduce private investors to selected, innovative start-up projects at an early stage. 

BioEntrepreneurs planning a spin-off or start-up in search of investors can apply with us to present their business idea to our BioAngels. The presenting teams will be prepared by us to submit all relevant information needed for deciding on an investment in an appropriate manner.

Focus on health care sector

Our circle of investors is interested in participating in the following areas:

  •     Innovative drug development
  •     New diagnosis procedures
  •     Big data & digital health
  •     New drug technologies and approaches to regenerative drugs
  •     Innovative platform technologies and services

     

    „On the BioAngels Pitch Day, it is easy to talk to the teams. That would be harder on large investment conferences. I also greatly appreciate the exchange with the other investors.“
    Dr. Hubert Birner, TVM Capital

     

    „The preparation by the team of BioM was very good and intensive. The criticizing feedback has helped us tailor our presentation to the demands of investors.“
    Dr. Kathrin Ladetzki-Baehs, adivo.


More about this topic

Merck x MAxL: Unlocking Genomic Technique potential - virtual

Merck x MAxL: Un­lock­ing Ge­nom­ic Tech­nique po­ten­tialDis­cov­er our ge­n­om­ic solu­tions, fea­tur­ing ad­vanced gene edit­ing tools,…

BayStartUP x BioM Pitch Day on 20 November 2025 – Apply NOW to find Investors for your Start-Up!

Fol­low­ing the great suc­cess of last year’s event, we’re ex­cited to build on that mo­mentum and bring you an­oth­er suc­cess­ful pitch…

Mettler Toledo x MAxL: Optimize your Cell count Analysis - Good Pipetting Techniques and Advanced Cell Counting using DHM

Have you ever faced delays in your work­flow due to pipet­ting er­rors? How con­fid­ent are you in the re­pro­du­cib­il­ity of your cell…

Dr. Petra Burgstaller
Dr. Petra Burgstaller

Incubation & MAxL Co-Lead, Portfolio Management


Christina Enke-Stolle
Christina Enke-Stolle

Incubation & MAxL Co-Lead, Partnership Management